Research collaboration develops new engineered T-cell therapy for type 1 diabetes (image)

Seattle Children's

Caption

Dr. Jane Buckner of the Benaroya Research Institute at Virginia Mason and Dr. David Rawlings at Seattle Children's Research Institute are leading research to develop an engineered T-cell therapy for type 1 diabetes.

Credit

Seattle Children's

Usage Restrictions

None

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.